Simon Loiodice

COO at AndzonBio2

Presenter

Simon has a PhD in neuropsychopharmacology with a strong entrepreneurial and business-driven mindset. He has 15 years of experience (gained in pharma, CRO and biotech) in early drug development with a primary focus on neuroscience. He also has significant experience in operational and strategic leadership as well as a track record in implementing and leading research collaborations with academic groups and biotech/pharma companies in the CNS space.

Simon previously founded and led 2 CNS biotech companies and is a biotech entrepreneur since 2020. Throughout his entrepreneurial journey, he gained significant experience in company building/structuring, project search & evaluation, deal making/negotiation and business development.

Prior to his entrepreneurial experiences, Simon worked 5 years (2016-2021) in a CRO as Head of CNS Pharmacology and was involved in multiple CNS drug development programs with leading European and US-based biotech/pharma. Before that, Simon notably had positions at UCB Pharma and Sanofi where he gained pharma experience in nonclinical pharmacology / drug safety evaluation.

Throughout his career, Simon has designed and executed multiple CNS drug development programs and led multiple translational neuroscience projects. His work notably resulted in various 1st author publications which were co-authored with leaders in the field.